Presentation is loading. Please wait.

Presentation is loading. Please wait.

Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee.

Similar presentations


Presentation on theme: "Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee."— Presentation transcript:

1 Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee

2 Capstone Project Chair Pharmacy and Therapeutics Committee for Catholic Health East Standardize Pharmacy to Match Standardized Order Sets Estimated Six Thousand Medications Estimated 350 Million Dollar Pharmacy Distributed Among East Coast Regional Health Centers

3 Barriers “Buy In” From The Regional Health Centers Creating A Strong Relationship With Various P&T Committees Developing Formulary and Evaluating Six Thousand Medications

4 Communication Is Top Priority Open lines of communication between the corporate pharmacists and those at the Regional Health Centers (RHCs) Monthly meetings, personal visits and regular phone conversations, email and power point updates

5 Ongoing Communication Find mutual needs of each group and bring them together using the power of the PTC to help meet those needs With the understanding that this is an ever changing project, help bridge the gap between changing corporate guidelines and RHC response and needs

6 Development of Calendar It is essential to have a calendar to use as a guide for the entire Pharmacy and Therapeutics Committee to follow It is understood that this calendar will be fluid in nature based on ever changing demands Representatives of RHCs need to have a clear voice in approval and development of this calendar

7 Formulary Development Leverage Resources From RHCs Interview Pharmacists From Each RHC To Determine Areas Of Interest Recognizing That Local RHCs Have Selected Medications Through Committee And Evidence Based Decisions

8 Formulary Development The formulary shall be reviewed at least annually The selection and deletion of formulary items shall be based upon objective evaluation of their relative therapeutic merits, safety, and estimated cost

9 Ongoing Roles Monitor and evaluate adverse drug reactions and medication errors; make appropriate recommendations for system changes to prevent such occurrences Develop programs and procedures that help ensure ongoing cost-effective use of drugs with emphasis placed on clinical effectiveness, safety and the total cost of therapy

10 Ongoing Roles Develop and monitor policies involving restrictions placed on the use of formulary and non-formulary drugs at CHE Provide professional and scientific input to the service and education functions of the Department of Pharmacy Educate physicians and other professional staff on matters pertaining to the use of drugs

11 Ongoing Roles Serve in an evaluative, educational, and advisory capacity to healthcare providers and hospital administration in matters pertaining to the use of drugs Develop a universal formulary policy and universal formulary associated standards of practice

12 Ongoing Roles Keep an eye toward defining formulary medication based on technical and operational feasibility as well as consistency with universal formulary policy Successful implementation at the RHC level of policies and procedures reviewed and approved by PTC


Download ppt "Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee."

Similar presentations


Ads by Google